V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20025413 | 20071309 | 1.64 | 71 | Adjuvant (A) | 2013-10-16 | 2013-10-17 | FEC + DOCETAXEL | 02 | null | 20089683 | FEC + DOCETAXEL |
| 20025414 | 20010808 | 1.73 | 83.45 | Not known (9) | 2014-09-28 | 2014-10-20 | FEC + DOCETAXEL | 02 | N | 20089684 | FEC + DOCETAXEL |
| 20025415 | 20010808 | 1.52 | 78 | Not known (9) | 2013-06-01 | 2013-06-06 | FEC + DOCETAXEL | 2 | null | 20089684 | FEC + DOCETAXEL |
| 20025416 | 20010808 | 1.73 | 63.6 | Adjuvant (A) | 2014-02-25 | 2014-03-13 | FEC + DOCETAXEL | 99 | N | 20089684 | FEC + DOCETAXEL |
| 20025417 | 20010809 | 1.52 | 83.1 | Neo-adjuvant (N) | 2014-09-30 | 2014-10-22 | FEC 100 + DOCETAXEL | N | null | 20089706 | FEC + DOCETAXEL |
| 20025418 | 20071311 | null | 63.5 | null | 2013-09-24 | 2013-10-08 | FEC 100 + DOCETAXEL | N | N | 20089709 | FEC + DOCETAXEL |
| 20025419 | 20071311 | 1.64 | 71.4 | Adjuvant (A) | 2013-10-26 | 2013-11-02 | FEC 100 + DOCETAXEL | 2 | N | 20089709 | FEC + DOCETAXEL |
| 20025420 | 20010810 | 1.54 | 80 | Adjuvant (A) | null | 2017-10-23 | FEC + DOCETAXEL | 1 | null | 20089715 | FEC + DOCETAXEL |
| 20025421 | 20010810 | null | null | null | 2013-03-04 | 2013-04-02 | FEC 100 + DOCETAXEL | N | N | 20089715 | FEC + DOCETAXEL |
| 20025422 | 20010810 | 1.54 | 62.8 | Curative (C) | 2014-05-08 | 2014-05-10 | FEC + DOCETAXEL | 02 | N | 20089715 | FEC + DOCETAXEL |
| 20025423 | 20010810 | 1.68 | 61.8 | Adjuvant (A) | null | 2015-09-18 | FEC + DOCETAXEL | N | null | 20089715 | FEC + DOCETAXEL |
| 20025424 | 20010811 | 1.58 | 61 | Adjuvant (A) | null | 2015-12-10 | FEC 100 + DOCETAXEL | N | null | 20089727 | FEC + DOCETAXEL |
| 20025425 | 20010811 | 1.67 | 128.5 | Not known (9) | 2014-02-21 | 2014-02-25 | FEC + DOCETAXEL | 02 | Y | 20089727 | FEC + DOCETAXEL |
| 20025426 | 20010811 | 1.61 | 54.6 | Adjuvant (A) | 2016-12-05 | 2016-12-26 | FEC 100 + DOCETAXEL | 02 | N | 20089727 | FEC + DOCETAXEL |
| 20025427 | 20010812 | 1.67 | 74.6 | Not known (9) | 2013-09-08 | 2013-09-08 | FEC + DOCETAXEL | 2 | N | 20089737 | FEC + DOCETAXEL |
| 20025428 | 20010813 | null | 105.5 | Neo-adjuvant (N) | 2014-02-24 | 2014-02-26 | FEC + DOCETAXEL | 02 | null | 20089741 | FEC + DOCETAXEL |
| 20025429 | 20010813 | 1.7 | 92 | Adjuvant (A) | 2017-07-15 | 2017-07-15 | FEC + DOCETAXEL | 2 | N | 20089741 | FEC + DOCETAXEL |
| 20025430 | 20010813 | 1.68 | 57.6 | Adjuvant (A) | 2016-12-21 | 2016-12-21 | FEC + DOCETAXEL | 02 | N | 20089741 | FEC + DOCETAXEL |
| 20025431 | 20010814 | 1.63 | 64.8 | Not known (9) | 2013-03-24 | 2013-04-13 | FEC + DOCETAXEL | 02 | null | 20089746 | FEC + DOCETAXEL |
| 20025432 | 20010814 | null | null | Adjuvant (A) | 2017-10-24 | 2017-11-07 | FEC 100 + DOCETAXEL | N | N | 20089746 | FEC + DOCETAXEL |
| 20025433 | 20108629 | 1.72 | null | Neo-adjuvant (N) | 2015-12-20 | 2016-01-05 | FEC + DOCETAXEL | N | N | 20089749 | FEC + DOCETAXEL |
| 20025434 | 20010815 | 1.57 | 94 | null | 2014-01-11 | 2014-01-31 | FEC + DOCETAXEL | N | N | 20089752 | FEC + DOCETAXEL |
| 20025435 | 20010816 | 1.75 | 78 | Adjuvant (A) | 2015-01-13 | 2015-01-14 | FEC 100 + DOCETAXEL | 02 | N | 20089755 | FEC + DOCETAXEL |
| 20025436 | 20010816 | 1.75 | 71 | Adjuvant (A) | 2016-03-11 | 2016-03-14 | FEC + DOCETAXEL | 2 | N | 20089755 | FEC + DOCETAXEL |
| 20025437 | 20010816 | 1.64 | 58.4 | Adjuvant (A) | 2014-01-13 | 2014-01-29 | FEC 100 + DOCETAXEL | 2 | N | 20089755 | FEC + DOCETAXEL |
| 20025438 | 20010816 | 1.72 | 97.2 | Neo-adjuvant (N) | null | 2016-09-04 | FEC + DOCETAXEL | N | N | 20089755 | FEC + DOCETAXEL |
| 20025439 | 20010816 | 1.54 | 113.9 | Curative (C) | 2017-08-17 | 2017-08-29 | FEC + DOCETAXEL | 02 | N | 20089755 | FEC + DOCETAXEL |
| 20025440 | 20010817 | 1.64 | 71.75 | Adjuvant (A) | 2013-10-11 | 2013-10-15 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20089768 | FEC + DOCETAXEL |
| 20025441 | 20010817 | 1.65 | null | Adjuvant (A) | 2014-03-23 | 2014-03-30 | FEC + DOCETAXEL | N | N | 20089768 | FEC + DOCETAXEL |
| 20025442 | 20010817 | null | 71.5 | Neo-adjuvant (N) | 2014-02-05 | 2014-03-14 | FEC 100 + DOCETAXEL | N | N | 20089768 | FEC + DOCETAXEL |
| 20025443 | 20010817 | 1.66 | 68 | Adjuvant (A) | null | 2018-01-05 | FEC + DOCETAXEL | N | N | 20089768 | FEC + DOCETAXEL |
| 20025444 | 20010818 | 1.64 | 62 | Adjuvant (A) | null | 2014-12-10 | FEC + DOCETAXEL | N | N | 20089780 | FEC + DOCETAXEL |
| 20025445 | 20010819 | 1.69 | 71 | Adjuvant (A) | 2016-06-18 | 2016-06-25 | FEC 100 + DOCETAXEL | N | N | 20089786 | FEC + DOCETAXEL |
| 20025446 | 20010820 | 1.66 | 111.4 | Adjuvant (A) | 2017-07-02 | 2017-07-03 | FEC + DOCETAXEL | 02 | null | 20089787 | FEC + DOCETAXEL |
| 20025447 | 20010821 | null | 47 | Adjuvant (A) | 2016-05-26 | 2016-06-19 | FEC + DOCETAXEL | N | N | 20089788 | FEC + DOCETAXEL |
| 20025448 | 20010822 | 1.6 | 66.6 | Adjuvant (A) | 2017-08-09 | 2017-08-09 | FEC 100 + DOCETAXEL | 2 | N | 20089789 | FEC + DOCETAXEL |
| 20025449 | 20010822 | 1.6 | 94 | Adjuvant (A) | 2015-07-06 | 2015-07-14 | FEC + DOCETAXEL | null | N | 20089789 | FEC + DOCETAXEL |
| 20025450 | 20010823 | 1.59 | null | Adjuvant (A) | 2015-11-23 | 2015-11-28 | FEC + DOCETAXEL | N | N | 20089799 | FEC + DOCETAXEL |
| 20025451 | 20010823 | 1.71 | 106.8 | Adjuvant (A) | 2016-11-29 | 2016-12-21 | FEC + DOCETAXEL | 02 | N | 20089799 | FEC + DOCETAXEL |
| 20025452 | 20010824 | 1.64 | 94.5 | Adjuvant (A) | null | 2017-07-26 | FEC + DOCETAXEL | null | null | 20089808 | FEC + DOCETAXEL |
| 20025453 | 20010824 | 1.53 | 130.9 | Adjuvant (A) | 2013-11-18 | 2013-11-19 | FEC 100 + DOCETAXEL | N | N | 20089808 | FEC + DOCETAXEL |
| 20025454 | 20010825 | 1.69 | 98.8 | Adjuvant (A) | 2014-08-23 | 2014-09-19 | FEC + DOCETAXEL | N | N | 20089815 | FEC + DOCETAXEL |
| 20025455 | 20010826 | 1.6 | 71 | Adjuvant (A) | 2016-03-05 | 2016-03-19 | FEC + DOCETAXEL | N | N | 20089820 | FEC + DOCETAXEL |
| 20025456 | 20010826 | 1.63 | 140 | Adjuvant (A) | 2015-11-10 | 2015-11-28 | FEC 100 + DOCETAXEL | 2 | N | 20089820 | FEC + DOCETAXEL |
| 20025457 | 20010826 | 1.75 | 95 | Neo-adjuvant (N) | 2014-10-19 | 2014-10-21 | FEC + DOCETAXEL | 02 | N | 20089820 | FEC + DOCETAXEL |
| 20025458 | 20010826 | 1.57 | 72.9 | Adjuvant (A) | 2014-05-28 | 2014-06-10 | FEC + DOCETAXEL | N | N | 20089820 | FEC + DOCETAXEL |
| 20025459 | 20010827 | 1.54 | 75.2 | Adjuvant (A) | 2014-06-13 | 2014-06-26 | FEC + DOCETAXEL | N | N | 20089831 | FEC + DOCETAXEL |
| 20025460 | 20010827 | 1.73 | 83.8 | Adjuvant (A) | 2017-06-06 | 2017-06-12 | FEC + DOCETAXEL | 02 | N | 20089831 | FEC + DOCETAXEL |
| 20025461 | 20010828 | 1.69 | 79 | Neo-adjuvant (N) | 2015-06-14 | 2015-06-16 | FEC + DOCETAXEL | 02 | Y | 20089834 | FEC + DOCETAXEL |
| 20025462 | 20010828 | 1.66 | 47.7 | Curative (C) | 2017-07-23 | 2017-08-06 | FEC + DOCETAXEL | 02 | N | 20089834 | FEC + DOCETAXEL |